Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer

Clinical trial NCT04733963 · UNKNOWN

Trial details

NCT number: NCT04733963
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2021-03-01
Primary completion: 2023-01-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.